Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.89 SEK | -1.60% | +0.55% | +11.30% |
Feb. 22 | Hansa Biopharma Hires New CFO | MT |
Feb. 22 | Hansa Biopharma AB Announces CFO Changes | CI |
Sales 2024 * | 265M 24.73M | Sales 2025 * | 402M 37.57M | Capitalization | 1.55B 144M |
---|---|---|---|---|---|
Net income 2024 * | -627M -58.53M | Net income 2025 * | -576M -53.77M | EV / Sales 2024 * | 8.68 x |
Net Debt 2024 * | 753M 70.27M | Net Debt 2025 * | 956M 89.25M | EV / Sales 2025 * | 6.22 x |
P/E ratio 2024 * |
-2.84
x | P/E ratio 2025 * |
-3.46
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | -1.60% | ||
1 week | +0.55% | ||
Current month | -7.84% | ||
1 month | -6.30% | ||
3 months | +3.40% | ||
6 months | -13.16% | ||
Current year | +11.30% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 18-03-19 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | Nov. 30 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 20-05-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Pedersen
BRD | Director/Board Member | 73 | 18-05-28 |
Peter Nicklin
CHM | Chairman | 61 | 22-06-29 |
Mats Blom
BRD | Director/Board Member | 59 | 19-05-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 29.18 | -0.61% | 21 337 |
24-03-27 | 29.36 | +1.24% | 41,619 |
24-03-26 | 29 | 0.00% | 45,304 |
24-03-25 | 29 | 0.00% | 73,120 |
24-03-22 | 29 | 0.00% | 85,134 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 06:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.30% | 146M | |
+9.16% | 45.97B | |
+54.48% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |